scispace - formally typeset
J

Joachim Klosterkötter

Researcher at University of Cologne

Publications -  280
Citations -  17298

Joachim Klosterkötter is an academic researcher from University of Cologne. The author has contributed to research in topics: Psychosis & Schizophrenia. The author has an hindex of 64, co-authored 268 publications receiving 15866 citations.

Papers
More filters
Journal ArticleDOI

The Psychosis High-Risk State: A Comprehensive State-of-the-Art Review

TL;DR: The relatively new field of HR research in psychosis has the potential to shed light on the development of major psychotic disorders and to alter their course and provides a rationale for service provision to those in need of help who could not previously access it.
Journal ArticleDOI

Diagnosing Schizophrenia in the Initial Prodromal Phase

TL;DR: The Bonn Scale for the Assessment of Basic Symptoms operationalization of prodromal symptoms performed well in the early detection of schizophrenia and might be useful for the prediction of the disorder, especially if it is further refined to select those items with particularly high prognostic accuracy.
Journal ArticleDOI

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

TL;DR: It is suggested that inhibition of anandamide deactivation may contribute to the antipsychotic effects of cannabidiol potentially representing a completely new mechanism in the treatment of schizophrenia.
Journal ArticleDOI

Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study

TL;DR: A differential predictive clinical model of transition to first-episode psychosis is developed that identified an increased risk of psychosis with appropriate prognostic accuracy in a sample of help-seeking patients.
Journal ArticleDOI

The nucleus accumbens: a target for deep brain stimulation in obsessive-compulsive- and anxiety-disorders.

TL;DR: The shell region of the right nucleus accumbens is chosen as target for deep brain stimulation (DBS) in a pilot-series of four patients with severe obsessive-compulsive- and anxiety-disorders, with significant reduction in severity of symptoms.